US80105N1054 - SNY - 662283 (XNAS)
SANOFI - AMERICAN DEPOSITARY SHARES Hinterlegungsschein
58,26 USD
Aktuelle Kurse von SANOFI - AMERICAN DEPOSITARY SHARES
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
SNY
|
USD
|
19.09.2024 23:02
|
58,26 USD
| 57,47 USD | 1,37 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 1,98 % | 6,74 % | 23,38 % | 22,70 % | 6,18 % | 29,70 % |
Firmenprofil zu SANOFI - AMERICAN DEPOSITARY SHARES Hinterlegungsschein
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Investierte Fonds
Folgende Fonds haben in SANOFI - AMERICAN DEPOSITARY SHARES investiert:
Fonds | Vol. in Mio 395,57 | Anteil (%) 0,93 % |
Unternehmensdaten SANOFI - AMERICAN DEPOSITARY SHARES Hinterlegungsschein
Name SANOFI - AMERICAN DEPOSITARY SHARES
Firma Sanofi
Symbol SNY
Website https://www.sanofi.com
Heimatbörse
NASDAQ
WKN 662283
ISIN US80105N1054
Wertpapierart Hinterlegungsschein
Sektor Healthcare
Branche Drug Manufacturers - General
CEO Mr. Paul Hudson
Marktkapitalisierung 141 Mrd.
Land Frankreich
Währung USD
Mitarbeiter 86,1 T
Adresse 54, Rue La BoEtie, 75008 Paris
IPO Datum 2002-07-01
Aktien-Splits
Datum | Split |
---|---|
30.09.2013 | 5:1 |
17.11.2010 | 10:1 |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | SNW2.F |
NASDAQ | SNY |
Weitere Aktien
Investoren die SANOFI - AMERICAN DEPOSITARY SHARES halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024